Drug Profile
Research programme: Parkinson's disease therapeutic lentivirus - American Gene Technologies
Alternative Names: AG PD 001; AG-PD - Parkinson's disease therapeutic lentivirusLatest Information Update: 13 Sep 2023
Price :
$50
*
At a glance
- Originator American Gene Technologies International
- Developer American Gene Technologies International; Johns Hopkins University
- Class Gene therapies
- Mechanism of Action Poly(ADP-ribose) polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Parkinson's disease